Variant report
Variant | nsv970078 |
---|---|
Chromosome Location | chr6:15846040-15849636 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:15843460..15845659-chr6:15846295..15848872,3 | K562 | blood: | |
2 | chr6:15849502..15852493-chr6:15865904..15869500,3 | K562 | blood: | |
3 | chr6:15849343..15852603-chr6:16131600..16134904,3 | K562 | blood: | |
4 | chr6:15847371..15849315-chr6:15851002..15853274,2 | K562 | blood: | |
5 | chr6:15847033..15849946-chr6:16004601..16006275,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533260640 | chr6:15846079-15846080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59217115 | chr6:15846126-15846127 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs576828283 | chr6:15846127-15846128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539347089 | chr6:15846130-15846131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143412033 | chr6:15846138-15846139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566907462 | chr6:15846144-15846145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527900244 | chr6:15846163-15846164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116574264 | chr6:15846235-15846236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371105517 | chr6:15846333-15846334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554249218 | chr6:15846377-15846378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56024112 | chr6:15846412-15846413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574155852 | chr6:15846429-15846430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549664210 | chr6:15846436-15846437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147127657 | chr6:15846463-15846464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562916966 | chr6:15846493-15846494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567981791 | chr6:15846510-15846511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185127894 | chr6:15846536-15846537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs220934 | chr6:15846701-15846702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs114091729 | chr6:15846720-15846721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528337086 | chr6:15846721-15846722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556669466 | chr6:15846782-15846783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568873451 | chr6:15846821-15846822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539155224 | chr6:15846826-15846827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567773720 | chr6:15846899-15846900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190460480 | chr6:15846908-15846909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114675195 | chr6:15846922-15846923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570066438 | chr6:15846930-15846931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181801084 | chr6:15846936-15846937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572660827 | chr6:15846940-15846941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566196733 | chr6:15846949-15846950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149736255 | chr6:15846962-15846963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554709351 | chr6:15846964-15846965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111263980 | chr6:15846984-15846985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543144045 | chr6:15847014-15847015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs115130424 | chr6:15847040-15847041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77622388 | chr6:15847047-15847048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs60163716 | chr6:15847119-15847120 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs145772075 | chr6:15847204-15847205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199865266 | chr6:15847205-15847206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200625186 | chr6:15847207-15847208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs1927588 | chr6:15847227-15847228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548029503 | chr6:15847231-15847232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs117173951 | chr6:15847235-15847236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542064800 | chr6:15847251-15847252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561889792 | chr6:15847274-15847275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146814954 | chr6:15847282-15847283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573575345 | chr6:15847323-15847324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201672520 | chr6:15847396-15847397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550338174 | chr6:15847423-15847424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570048444 | chr6:15847467-15847468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17142309 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:15843000-15855400 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr6:15843800-15849400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
3 | chr6:15844000-15846200 | Enhancers | GM12878-XiMat | blood |
4 | chr6:15844200-15849400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:15848200-15848400 | Weak transcription | Aorta | Aorta |
6 | chr6:15849000-15849600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr6:15849400-15850600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr6:15849400-15850800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr6:15849600-15849800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr6:15849600-15850000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr6:15849600-15850800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |